Study factors associated with the incompletion of clinical trials that include pediatric patients: a retrospective analysis of the European Clinical Trials Database and a lesson from the European region
Abstract Background Incomplete clinical trials for pediatric drug development result in a lack of adequate scientific evidence for providing appropriate medication to pediatric populations; this is especially true for Japan. Thus, using the European Clinical Trials Database (EudraCT), this study aim...
Main Authors: | Nanae Tanemura, Tsuyoshi Sasaki, Junko Sato, Hisashi Urushihara |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-03-01
|
Series: | Trials |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13063-021-05143-6 |
Similar Items
-
Partnership of I-ACT for children (US) and European pediatric clinical trial networks to facilitate pediatric clinical trials
by: Eva Degraeuwe, et al.
Published: (2024-11-01) -
Prevention of cisplatin‐induced hearing loss in children: Informing the design of future clinical trials
by: Lori M. Minasian, et al.
Published: (2018-07-01) -
Descriptive Analysis of Pediatric Studies Included in the European Union Post-Authorization Study Register from 2010 to 2023
by: Annalisa Landi, et al.
Published: (2025-02-01) -
Workshop AIEOP... in Lab, Catania, 19-20 May 2011
by: AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica)
Published: (2011-06-01) -
Workshop AIEOP... in Lab, Milano, 22-23 October 2009
by: AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica)
Published: (2009-10-01)